Document is current

Article History

Received: 9 June 2025

Accepted: 23 March 2026

First Online: 2 April 2026

Declarations

:

: No human participants were included in this study. This was a review of de-identified administrative claims data. Informed consent was not obtained. Due to the nature of the study, Institutional Review Board/Ethics Committee approval was not required. No animal subjects were included in this study.

: Not applicable.

: PA is a consultant for Regeneron Pharmaceuticals Inc.; and has received research grants from UTHSC (The University of Tennessee Health Science Center). EKA has no relevant disclosures. JFM is a consultant and/or investigator for AbbVie, Amgen, Biogen, Boehringer Ingelheim, BMS, Dermavant, Eli Lilly, Incyte, Janssen, LEO Pharma, Novartis, Pfizer, Regeneron Pharmaceuticals Inc., Sanofi, Sun Pharma, and UCB. JPT is an advisor for AbbVie, Almirall, Arena Pharmaceuticals, ASLAN Pharmaceuticals, Eli Lilly, LEO Pharma, OM Pharma, Pfizer, Regeneron Pharmaceuticals Inc., Sanofi, and UNION Therapeutics; is a speaker for AbbVie, Almirall, Eli Lilly, LEO Pharma, Pfizer, Regeneron Pharmaceuticals Inc., and Sanofi; has received research grants from Pfizer, Regeneron Pharmaceuticals Inc., and Sanofi; and is a part-time employee of LEO Pharma, since May 1, 2023. AM and MA are employees and shareholders of Regeneron Pharmaceuticals Inc. RL and DS are employees of Sanofi and may hold stock and/or stock options.